Preview Mode Links will not work in preview mode

May 3, 2021

Proceedings from the first in a 2-part nursing webinar series. Featuring perspectives from Ms Rhonda Hewitt and Dr Mark Levis, including the following topics:

  • Introduction (0:00)
  • Case: A man in his early 80s with newly diagnosed poor-risk acute myeloid leukemia (AML) — Rhonda Hewitt, MSN, ANP, AOCNP (1:08)
  • Molecular evaluation of patients with newly diagnosed AML (15:21)
  • Venetoclax combinations for AML and management of tumor lysis syndrome (22:14)
  • Case: A man in his early 80s with AML and a FLT3 ITD mutation — Mark Levis, MD, PhD (37:15)
  • Management of AML with a FLT3 mutation (40:59)
  • Management of AML with an IDH mutation (51:07)
  • Other novel agents and strategies for AML (56:26)

CME information and select publications